Novogene
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A global genomics service provider enabling research and diagnostics through advanced sequencing and bioinformatics.
Genetics & GenomicsDiagnostics
Technology Platform
Industrial-scale next-generation sequencing (NGS) infrastructure coupled with proprietary bioinformatics and data analysis pipelines.
Opportunities
Expansion into clinical diagnostics and data-as-a-service models in emerging markets presents significant growth potential.
Risk Factors
Heavy reliance on capital expenditure for new sequencing instruments and vulnerability to drastic price erosion in the sequencing market.
Competitive Landscape
Faces intense competition from BGI and international giants like Illumina in the sequencing service market, competing on scale, cost, and data quality.